Redeye returns following IRLAB's Q1 report and the news of a development collaboration related to IRL757 in apathy. We are overall encouraged by IRLABs progress lately and raise our valuation.
ANNONS
Redeye returns following IRLAB's Q1 report and the news of a development collaboration related to IRL757 in apathy. We are overall encouraged by IRLABs progress lately and raise our valuation.